IJGC conversations

ijgcgroup
  • 4.0 (4)
  • Medicine

The International Journal of Gynecological Cancer (IJGC) conversations is a podcast that brings you the latest insights into gynecologic malignancies. Tune in to engaging conversations with leading experts as they explore innovative and timely topics shaping the field. Hosted by the Editor-in-Chief Dr. Pedro Ramirez and special guests, each episode offers a dynamic and educational experience designed for clinicians, researchers, and anyone passionate about advancing gynecologic cancer care. Subscribe today or stream on your favorite podcast platform. IJGC - https://www.sciencedirect.com/journal/international-journal-of-gynecological-cancer - proudly serves as the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

  1. 10h ago

    KEYNOTE-B96: Pembrolizumab and Weekly Paclitaxel in Ovarian Cancer

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Emese Zsiros to discuss KEYNOTE-B96: Pembrolizumab and Weekly Paclitaxel in Ovarian Cancer.   Emese Zsiros, MD, PhD, FACOG, is Chair of the Department of Gynecologic Oncology and the Shashi Lele, MD Endowed Chair at Roswell Park Comprehensive Cancer Center, where she is also Professor of Oncology and co-leader of the Tumor Immunology and Immunotherapy Program. A high-volume gynecologic oncologic surgeon and clinical investigator, Dr. Zsiros specializes in the surgical and medical treatment of ovarian, endometrial, cervical, and other gynecologic cancers, with expertise in minimally invasive surgery, immunotherapy, cell-based therapies, and innovative clinical trials. She has contributed to more than 150 clinical trials and leads research focused on overcoming treatment resistance, improving immunotherapy, and integrating artificial intelligence and data-driven approaches into personalized cancer care. Dr. Zsiros earned her MD and PhD from the University of Debrecen in Hungary, completed her OB/GYN residency at Northwestern University, and trained in Gynecologic Oncology at the University of Pennsylvania. She joined Roswell Park in 2014 and became the institution’s first female surgical chair in 2022. Her work is driven by a commitment to surgical excellence, scientific innovation, mentorship, and improving both outcomes and quality of life for women with gynecologic cancers. Her recent work, “Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study,“ is published in the Lancet.

  2. Sep 7

    FIGO/IGCS Statement on Topical Treatments for HPV CIN3+

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. René Pareja to discuss FIGO/IGCS Statement on Topical Treatments for HPV CIN3+.   Dr. René Pareja is a Gynecologist and Obstetrician, graduated from Universidad Pontificia Bolivariana in Medellín, Colombia in 2000; he finished his training in Gynecologic Oncology in 2003, from Pontificia Universidad Javeriana and Instituto Nacional de Cancerología in Bogotá, Colombia. He is a minimally invasive surgeon, graduated from Corporación de Estudios de la Salud (CES) in 2013. He currently works at Astorga Oncology Clinic in Medellín and at National Cancer Institute in Bogotá, Colombia. Dr. Pareja serves as a reviewer for more than 20 journals. He has authored or co-authored nine book chapters and more than fifty publications in peer-reviewed journals. Currently he is an Associate Editor of the International Journal of Gynaecological Cancer and is a Council member of the International Gynecological Cancer Society Council. He also serves as an international mentor for the Hospital General San Juan de Dios in Guatemala through the IGCS Global Curriculum & Mentorship Program.Some of his research has influenced how gynecologic oncologists treat cancer and has been published in important medical journals, like the New England Journal of Medicine, JAMA, and Journal of Clinical Oncology.

  3. Jul 31

    GLP1-RAs and Cancer Risk in Non-diabetic Patients

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Aparna A. Kamat and Arthur Hsu to discuss GLP1-RAs and Cancer Risk in Non-diabetic Patients.   Dr. Aparna Kamat is the director of the Division of Gynecologic Oncology for Houston Methodist and is currently the section leader for the Gynecologic Oncology service line. After completing medical training in India, Dr. Kamat completed her residency in OB/GYN at West Virginia University, where she served as chief resident. She completed her fellowship training in Gynecologic Oncology at the MD Anderson Cancer Center. During her fellowship, she received multiple awards for her research in ovarian cancer and endometrial cancer, including the Virginia K. Pierce award and the Asche Murray fellowship. She also received the prestigious BIRCWH award from the N.I.H. for her research in biomarkers for ovarian cancer. Dr. Kamat currently is the principal investigator for the Gynecologic Oncology Group Clinical Trials Program at Houston Methodist and offers several state-of-the-art clinical trials for patients with gynecologic malignancies. She serves on the board of Ovarcome – a non-profit organization that provides support for women with ovarian cancer and was named Ovarcome Hero of the Year. Her areas of expertise are robotic and minimally invasive surgical options for women with gynecologic cancers and complex pelvic disease. Her other clinical interests include hereditary risk assessment and treatment of gynecologic malignancies.   Arthur Heng-Cheng Hsu, MD, is a gynecologic oncologist at the National Taiwan University Hospital and focuses on surgery, cancer therapy, and patient recovery. He serves as the Director of Journal Operations for the International Journal of Gynecological Cancer (IJGC). His recent work is published in the Annals of Oncology exploring GLP-1 receptor agonist use and cancer risk in obese, non-diabetic adults.

  4. Jul 15

    Statin Use in Gynecologic Cancer Therapy

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Paula Mateo-Kubach and Behrouz Zand to discuss Statin Use in Gynecologic Cancer Therapy.   Paula Mateo-Kubach, MD, is a Spanish physician who completed her residency training in Obstetrics and Gynecology in Toledo, Spain. She is currently a Research Fellow at Houston Methodist Hospital, where her work focuses on perioperative care and Enhanced Recovery After Surgery (ERAS). In parallel, she is pursuing a PhD at Universidad Autónoma de Madrid, with research centered on ERAS implementation challenges and opioid use in surgical care. Her next goal is to complete clinical training in gynecologic oncology.​​​​​​​​​​​​​​​​ When she is not filling her database, she can be found underwater, she is a PADI-certified rescue diver.   Dr. Behrouz Zand is a gynecologic oncologist at Houston Methodist Hospital's Neal Cancer Center and Department of Obstetrics and Gynecology, and an assistant professor at Weill Cornell College at Houston Methodist Academic Institute. Specializing in innovative cancer care and clinical trials, he is passionate about integrating AI in medicine, a recent alumnus of the physician program at MIT for AI integration in healthcare. Dr. Zand combines cutting-edge research with compassionate patient care to advance the field.

  5. Jul 6

    Empty Lymph Node Packet in SLN Mapping for Endometrial Cancer

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Sarah Andres and Mario M. Leitao Jr to discuss Empty Lymph Node Packet in SLN Mapping for Endometrial Cancer.   Sarah Andres, DO, FACOG, is a Gynecologic Oncology Fellow at Memorial Sloan Kettering Cancer Center (MSKCC), with planned graduation in June, 2027. She additionally works within the Weigelt Laboratory conducting translational research and studying rare gynecologic malignancies. Dr. Andres has contributed extensively to the field through her recent research, with work published in leading journals such as Gynecologic Oncology and the International Journal of Gynecological Cancer. Her recent publications explore critical topics including sentinel lymph node mapping techniques in uterine cancer, outcomes of neoadjuvant chemotherapy for advanced ovarian cancer, and genomic characterization of endometrial serous carcinoma. Her clinical and research interests span cervical, endometrial, and ovarian carcinoma, with contributions to multiple clinical trials and retrospective studies.   Dr. Mario M. Leitao, Jr., MD, FACOG, FACS, is currently an Attending Surgeon in the Department of Surgery at Memorial Sloan Kettering Cancer Center and a Professor in the Department of Obstetrics and Gynecology at Weill Cornell Medical College. He currently serves as Program Director for the Gynecologic Oncology Fellowship. Dr. Leitao is also the Director for the Minimal Access and Robotic Surgery Program in the Department of Surgery for MSKCC. Dr. Leitao is the recipient of the 2025 IGCS Excellence in Teaching Award.

  6. Jun 30

    Contralateral pelvic lymph node metastases in patients with unilateral early-stage epithelial ovarian cancer

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Santiago Vieira-Serna to discuss Contralateral pelvic lymph node metastases in patients with unilateral early-stage epithelial ovarian cancer.   Dr. Santiago Vieira-Serna is a gynecologic oncologist who graduated from the Instituto Nacional de Cancerología in Bogotá, Colombia, in 2023. He currently works at the Instituto Nacional de Cancerología and at Clínica Universitaria Colombia.

  7. Jun 1

    Salpingo-oophorectomy at Radical Hysterectomy for Cervical Adenocarcinoma

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Gabriel Levin to discuss Salpingo-oophorectomy at Radical Hysterectomy for Cervical Adenocarcinoma.   Dr. Gabriel Levin is a gynecologic oncologist and clinical researcher at McGill University and the McGill University Health Centre. His work focuses on real-world outcomes research, and health systems innovation in gynecologic cancers. He has authored more than 330 peer-reviewed publications and is actively involved in advancing evidence-based care through academic leadership and international collaboration.

  8. May 25

    Lymphadenectomy in Early-Stage Ovarian Cancer

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Giuseppe Caruso to discuss Lymphadenectomy in Early-Stage Ovarian Cancer.   Dr. Giuseppe Caruso, MD PhD works as a consultant gynecologic oncologist at the European Institute of Oncology (IEO), Milan (Italy), under the mentorship of Prof. Nicoletta Colombo. He holds a PhD in “Network Oncology and Precision Medicine” from the Department of Experimental Medicine, Sapienza University of Rome. He is a research collaborator at Mayo Clinic, Rochester (MN, USA); an honorary faculty member of the European School of Oncology (ESO) College; and a member of the European Network of Young Gynae Oncologists (ENYGO) Executive Group.

See All (83)

Ratings & Reviews

4
out of 5
4 Ratings

About

The International Journal of Gynecological Cancer (IJGC) conversations is a podcast that brings you the latest insights into gynecologic malignancies. Tune in to engaging conversations with leading experts as they explore innovative and timely topics shaping the field. Hosted by the Editor-in-Chief Dr. Pedro Ramirez and special guests, each episode offers a dynamic and educational experience designed for clinicians, researchers, and anyone passionate about advancing gynecologic cancer care. Subscribe today or stream on your favorite podcast platform. IJGC - https://www.sciencedirect.com/journal/international-journal-of-gynecological-cancer - proudly serves as the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

Information

  • Creator
    ijgcgroup
  • Years Active
    2024 - 2026
  • Episodes
    83
  • Rating
    Clean
  • Copyright
    © Copyright 2024 All rights reserved.
  • Show Website
    IJGC conversations

You Might Also Like